Market research
9776.TSE Sapporo Clinical Laboratory Inc
TSE JPY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 35K
- P/E ratio
- 0.0
- Analyst target
- Not available
- Dividend yield
- 1.2%
- Beta
- 0.35
Community
Investor discussion
1 comment
Sign in to join the 9776.TSE discussion.
5 years, 5 months ago
Sapporo Clinical Laboratory Inc is currently in a long term uptrend where the price is trading 5.7% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.3.
Sapporo Clinical Laboratory Inc's total revenue rose by 2.5% to $5B since the same quarter in the previous year.
Its net income has increased by 52.0% to $258M since the same quarter in the previous year.
Based on the above factors, Sapporo Clinical Laboratory Inc gets an overall score of 4/5.